Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Filed Chapter 11
|
|
NephroGenex, Inc. (NRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/10/2015 |
4
| Steiner Eugen (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 76,045 shares
@ $0 |
|
| 11/12/2015 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 646,930 shares
@ $0 |
|
| 11/12/2015 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 11/12/2015 |
4
| Patel Jaikrishna (Chief Medical Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 97,306 shares
@ $0 |
|
| 09/01/2015 |
4
| Fox J. Wesley (Pres. & Chief Sci. Officer) has filed a Form 4 on NephroGenex, Inc. |
| 08/07/2015 |
4
| Patel Jaikrishna (Chief Medical Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 54,347 options to buy
@ $4.12, valued at
$223.9k
|
|
| 05/04/2015 |
4
| Taglietti Marco (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 6,870 options to buy
@ $7.31, valued at
$50.2k
|
|
| 05/04/2015 |
4
| Steiner Eugen (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 6,870 options to buy
@ $7.31, valued at
$50.2k
|
|
| 05/04/2015 |
4
| Seltzer Robert R. (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 6,870 options to buy
@ $7.31, valued at
$50.2k
|
|
| 05/04/2015 |
4
| Peterson Bob (VP of Prod. Dev. & Reg. Aff's.) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 11,500 options to buy
@ $7.31, valued at
$84.1k
|
|
| 05/04/2015 |
4
| Mitchum James P. (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 13,740 options to buy
@ $7.31, valued at
$100.4k
|
|
| 05/04/2015 |
4
| Markham Richard J (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 6,870 options to buy
@ $7.31, valued at
$50.2k
|
|
| 05/04/2015 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 50,000 options to buy
@ $7.31, valued at
$365.5k
|
|
| 05/04/2015 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 05/04/2015 |
4
| Fox J. Wesley (Pres. & Chief Sci. Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.31, valued at
$109.7k
|
|
| 01/06/2015 |
4
| Rho Ventures V, L.P. (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Sold 88,000 shares
@ $10.8319, valued at
$953.2k
Sold 164,919 shares
@ $10.5389, valued at
$1.7M
Sold 20,941 shares
@ $9.9011, valued at
$207.3k
|
|
| 12/15/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 12/15/2014 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 150,000 options to buy
@ $4.67, valued at
$700.5k
|
|
| 12/15/2014 |
4
| Peterson Bob (VP of Prod. Dev. & Reg. Aff's.) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 33,500 options to buy
@ $4.67, valued at
$156.4k
|
|
| 12/15/2014 |
4
| Fox J. Wesley (Pres. & Chief Sci. Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 45,000 options to buy
@ $4.67, valued at
$210.2k
|
|
| 11/25/2014 |
4
| Peterson Bob (VP of Prod. Dev. & Reg. Aff's.) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Bought 2,000 shares
@ $4.2, valued at
$8.4k
|
|
| 10/02/2014 |
4
| Taglietti Marco (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 22,656 options to buy
@ $4.49, valued at
$101.7k
|
|
| 08/15/2014 |
4
| Fox J. Wesley (Pres. & Chief Sci. Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 28,000 options to buy
@ $4.49, valued at
$125.7k
|
|
| 08/15/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 08/15/2014 |
4
| Peterson Bob (VP of Prod. Dev. & Reg. Aff's.) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 21,000 options to buy
@ $4.49, valued at
$94.3k
|
|
| 05/16/2014 |
4
| Steiner Eugen (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 3,076 options to buy
@ $11.9, valued at
$36.6k
|
|
| 05/16/2014 |
4
| Hamill John (CFO) has filed a Form 4 on NephroGenex, Inc. |
| 05/16/2014 |
4
| Seltzer Robert R. (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 3,076 options to buy
@ $11.9, valued at
$36.6k
|
|
| 05/16/2014 |
4
| Markham Richard J (10% Owner) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 3,076 options to buy
@ $11.9, valued at
$36.6k
|
|
| 05/16/2014 |
4
| Peterson Bob (VP of Prod. Dev. & Reg Aff's.) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 11,538 options to buy
@ $11.9, valued at
$137.3k
|
|
| 05/16/2014 |
4
| VOGELBAUM MARTIN (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 3,076 options to buy
@ $11.9, valued at
$36.6k
|
|
| 05/16/2014 |
4
| Mitchum James P. (Director) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 3,076 options to buy
@ $11.9, valued at
$36.6k
|
|
| 05/16/2014 |
4
| Legault Pierre (CEO) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 76,156 options to buy
@ $12, valued at
$913.9k
Granted 38,078 options to buy
@ $12, valued at
$456.9k
Granted 24,686 options to buy
@ $2.02, valued at
$49.9k
Granted 12,343 options to buy
@ $2.02, valued at
$24.9k
|
|
| 05/16/2014 |
4
| Fox J. Wesley (Pres. & Chief Sci. Officer) has filed a Form 4 on NephroGenex, Inc.|
Txns:
| Granted 15,384 options to buy
@ $11.9, valued at
$183.1k
|
|
|
|
|